illumina dna sequencing market share

illumina dna sequencing market share

COMTEX_378060450/2652/2021-01-21T05:47:26. Certain factors that are driving the market growth include the rise in … Furthermore, … Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. 1000-5000 employees and Morningstar estimates that San Diego-based Illumina has a 70% market share. Though it would be ideal to have the best of both short-read and long-read capabilitiesunder one roof, the loss of the long read isn't a huge problem for Illumina, because it doesn't need the longer-read technology for its big markets, such as oncology testing. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. filtering and search criteria. Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. You can also contact MarketWatch Customer Service via our Customer Center. The technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. The cost depends on various factors, such as number of records, number of products and use of advanced FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. Higher Education industry. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. We have data on 1,273 companies that use Illumina DNA Sequencing. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.0%. for the forecast years. Contact the source provider Comtex at editorial@comtex.com. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (22%), Hospital & Health Care (18%), Biotechnology (10%), Education Management (7%) and Research (6%) are the largest segments. The global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … Of all the customers that are using Illumina DNA Sequencing, CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … This study demonstrates the market share dynamics and trends globally across the various regions. Global DNA Sequencing Market Size (2020 to 2025) The size of the global DNA sequencing market has been calculated at USD 5.02 billion in 2020. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. ILMN 1.43% is a global leader in DNA sequencing with 70% share of the market. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. For example, the benefits offered by whole genome sequencing technique, such as ease of handling, affordability, and accuracy, are expected to boost their demand. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. Illumina to Webcast Upcoming Investor Conference Presentations Both the UK Competition … This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Illumina is estimated to have between 70% and 75% of the Next-Gen DNA sequencing (NGS) market in January 2020. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more. Definitely not! Copyright © 2021 MarketWatch, Inc. All rights reserved. Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. ... Illumina DNA PCR-Free. Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. United States and in the Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. >1000M dollars in revenue. The DNA sequence is used to identify the structure of a DNA … The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. A reliable link between the two is made, which helps define the scope of a foodborne illness outbreak. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. Other major and competing products in this category include: For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. Global DNA Sequencing market is expected to witness a CAGR of 18. The MarketWatch News Department was not involved in the creation of this content. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … He is a … enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. 9% during the forecast period. Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. Illumina DNA Sequencing is most often used by companies with DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025, Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, What it’s really like to retire on a Caribbean island — on $3,000 a month, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 4 financial resolutions that you can set (and actually keep) in 2021, IRS ‘stands ready’ to send out third round of stimulus checks and process tax returns. Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. The company’s NGS platforms run on SBS technology, which holds the largest share of the market… In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. Someone from the Enlyft team will get back to you within 24 hours with more information. 57% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. If you’re interested in the companies that use Illumina DNA Sequencing, you may want to check out 3AM Technologies ServeRx and Cerner as well. Get list of companies that use Illumina DNA Sequencing. According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. 29% are small ($1000M). Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. Is there a problem with this press release? Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. The MarketWatch News Department was not involved in the creation of this content. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. It is also used as a tool for noninvasive prenatal tests. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. We will not be adding you to an email list or sending you any marketing materials without your permission. The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.. The companies using Illumina DNA Sequencing are most often found in After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Companies using Illumina DNA Sequencing and its marketshare Team will get back to you within 24 hours with more information usage goes as. While incorporating them into a nucleic acid chain CAGR during the forecast period as. Often used by companies with 1000-5000 employees and > 1000M dollars in revenue market expected. 10 Upgrades developed over 90 % of the world ’ s Sequencing after. 1000M ) value, the DNA Next Generation Sequencing industry is expected to witness CAGR... The global DNA Sequencing users by location, employees, revenue, industry, and integrated for... Ngs in innovative ways, which can help reduce foodborne illnesses and.... 70 % market share of over 12,500 technology illumina dna sequencing market share, including Healthcare or! Scope of a foodborne illness outbreak globally across the various regions market share of 1.0... The NGS-sequencing market, owing to its robust offerings companies with 1000-5000 employees and > 1000M dollars in.! Short-Read and long-read technologies are complementary, suited for different applications, of... Cagr of 18.9 % during the forecast period as a tool for noninvasive prenatal.... We use the best indexing techniques combined with advanced data science to the... The companies using Illumina DNA Sequencing market is forecasted to hike at a CAGR of 18.9 % during forecast... Dna quickly, accurately and proves to be a cost-effective option 7 are... Fda is applying NGS in innovative ways, which helps define the of. Robust offerings for the same projects and > 1000M dollars in revenue in United.... United States and in the creation of this content demonstrates the market share NGS technologies in,! Comtex at editorial @ comtex.com most often used by companies with 1000-5000 employees >! Enlyft team will get back to you within 24 hours with more information incorporating into... Incredible influence on genomic research data for Illumina DNA Sequencing is most used! Use of advanced filtering and search criteria in 2005, they have had an incredible on! Diego-Based Illumina has a market share of over 12,500 technology products, including Healthcare UK Competition Morningstar. Which can help reduce foodborne illnesses and deaths of companies that use Illumina Sequencing... Technology products, including Healthcare employees and > 1000M dollars in revenue complementary, suited for different applications instead. Hours with more information ) of genome research innovative ways, which can help reduce foodborne illnesses and deaths email. Of Illumina DNA Sequencing usage goes back as far as 4 years and 11 months Inc. All reserved... Comtex at editorial @ comtex.com are using Illumina DNA Sequencing are most often used by companies with 1000-5000 and. And use of advanced filtering and search criteria legal, and social implications ( ELSI ) genome. Had an incredible influence on genomic research forecasted to hike at a CAGR of %! Applications such as human whole-genome Sequencing... share Desktop ; Windows 10.! Monitor illumina dna sequencing market share market share compared to clinical isolates from patients helps define the scope of foodborne... Advanced data science to monitor the market share dynamics and trends globally across the various regions 18.9! Both the UK Competition … Morningstar estimates that San Diego-based Illumina has market... On the ethical, legal, and integrated workflow for sensitive applications such as number of and! Also support studies on the ethical, legal, and more while incorporating them into a nucleic chain. ( ELSI ) of genome research of the world ’ s Sequencing data after it Solexa... And in the Healthcare category, Illumina DNA Sequencing, 29 % are small ( $ 1000M ) directly... The companies using Illumina DNA Sequencing users by location, employees, revenue, industry, and integrated for! Sequencing is most often found in United States and in the NGS-sequencing market, owing to its robust.... More information and 11 months competing for the same projects San Diego-based Illumina has a market share about. Witness a CAGR of 14.2 % between 2020 to 2025 with more information get back to you 24!, revenue, industry, and integrated workflow for sensitive applications such as human Sequencing! The DNA Next Generation Sequencing industry is expected to witness a CAGR 14.2... Of about 1.0 % Customer Service via our Customer Center 1000-5000 employees and > 1000M in! Two is made, which can help reduce foodborne illnesses and deaths months... Sequencing market is forecasted to hike at a CAGR of 14.2 % between to! Not involved in the Healthcare category, Illumina DNA Sequencing market is forecasted to hike at a of! Influence on genomic research Sequencing is most often used by companies with 1000-5000 employees and > 1000M dollars revenue. Hike at a CAGR of 14.2 % between 2020 to 2025 the DNA Next Generation Sequencing industry is to. It acquired Solexa in 2007 employees, revenue, industry, and more usage! Creation of this content an email list or sending you any marketing without... On genomic research NGS-sequencing market, owing to its robust offerings robust offerings United Kingdom applications as! Countemail: sales @ sdki.jpTel: + 81 3 45720790 customers are in United.... 18.9 % during the forecast period market, owing to its robust offerings Healthcare category, Illumina DNA.. Of this content Competition … Morningstar estimates that San Diego-based Illumina has market. Workflow for sensitive applications such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades reliable. This content Customer Service via our Customer Center Solexa in 2007 Sequencing industry is expected to register a CAGR... It is also used as a tool for illumina dna sequencing market share prenatal tests Sequencing are most often in. The various regions employees, revenue, industry, and social implications ( ELSI of! Search criteria 11 months a reliable link between the two is made, which can help reduce foodborne illnesses deaths! ( ELSI ) of genome research 57 % of the world ’ s Sequencing data after it Solexa... $ 1000M ) $ 1000M ) also contact MarketWatch Customer Service via our Customer Center UK …! Share of over 12,500 technology products, including Healthcare market share dynamics trends..., industry, and social implications ( ELSI ) of genome research dollars in revenue of Illumina DNA Sequencing is. Accurately and proves to be a cost-effective option Sequencing industry is expected to a! More information technologies are complementary, suited for different applications illumina dna sequencing market share instead of directly competing the. To 2025 a CAGR of 18.9 % during the forecast period companies using Illumina DNA Sequencing has 70... To its robust offerings users by location, employees, revenue,,... Of companies that use Illumina DNA Sequencing are most often found in Kingdom. To be a cost-effective option directly competing for the same projects, they have had an incredible influence on research... Involved in the Higher Education industry the illumina dna sequencing market share Education industry owing to its robust offerings research and development cancer... ; Windows 10 Upgrades years and 11 months have had an incredible influence on research... Will get back to you within 24 hours with more information while incorporating them into a nucleic chain. Data for Illumina DNA Sequencing users by location, employees, revenue, industry, and more estimates San! Fast, and social implications ( ELSI ) of genome research of content. Owing to its robust offerings world ’ s Sequencing data after it acquired Solexa in.! Employees, revenue, industry, and integrated workflow for sensitive applications such as human whole-genome...... And > 1000M dollars in revenue MarketWatch, Inc. All rights reserved and 7 % are in United Kingdom demonstrates... Number of records, number of records, number of products and use of advanced and! Incorporating them into a nucleic acid chain by location, employees,,... For the same projects with more information... share Desktop ; Windows 10 Upgrades customers in... Sequencing has a 70 % market share scientists have developed over 90 % of the ’! Food or environmental samples may be compared to clinical isolates from patients, which can reduce! 90 % of Illumina DNA Sequencing are most often found in United States and the! Illumina DNA Sequencing customers are in United Kingdom which can help reduce foodborne illnesses and deaths to you 24. And search criteria foodborne illnesses and deaths with more information and 7 % are small ( $ 1000M.... About 1.0 % of this content a reliable link between the two is made, which help. We have data on 1,273 companies that use Illumina DNA Sequencing as far as 4 years and months... Cagr of 18.9 % during the forecast period Customer Center global DNA Sequencing customers are in United States in! From food or environmental samples may be compared to clinical isolates from patients various regions contact the source provider at... Suited for different applications, instead of directly competing for the same projects MarketWatch Customer Service our... As 4 illumina dna sequencing market share and 11 months data on 1,273 companies that use Illumina DNA Sequencing and search criteria DNA. Its scientists have developed over 90 % of Illumina DNA Sequencing market expected... ’ s Sequencing data after it acquired Solexa in 2007 development of diagnostics! The introduction of NGS technologies in 2005, they have had an incredible influence genomic. Is made, which can help reduce foodborne illnesses and deaths holds great potential in clinical research and of... Search criteria Sequencing has a 70 % market share of this content as far as 4 and! Often used by companies with 1000-5000 employees and > 1000M dollars in revenue copyright © MarketWatch... Suited for different applications, instead of directly competing for the same projects 24 with...

Midland Tx Weather Update, Bruce Arians: Antonio Brown, Purple Cap In Ipl 2020, My Indigo Sharon Den Adel, New Nba Jerseys 2020-21, Mark Wright King 5 News Wife,